menu
    • menu

    Company profile for Baring Private Equity Asia

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 1997, we’re dedicated to the Asian region and have $21 billion of FPAUM. We add value by working hand-in-hand with our portfolio companies, providing capital for expansion, recapitalization, or acquisitions, in order to grow their business for the long-term. Drawing on 25 years of experience throughout multiple economic cycles, our investment philosophy is deeply rooted in the principles of capital preservatio...
    Founded in 1997, we’re dedicated to the Asian region and have $21 billion of FPAUM. We add value by working hand-in-hand with our portfolio companies, providing capital for expansion, recapitalization, or acquisitions, in order to grow their business for the long-term. Drawing on 25 years of experience throughout multiple economic cycles, our investment philosophy is deeply rooted in the principles of capital preservation: diversified portfolios; margin of safety in pricing; and downside protection to limit losses. As a result, our returns have significantly outperformed public markets in Asia, by an average of 15% compounded by annum.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Baring Private Equity AsiaChina Flag
    Country
    Country
    China
    Address
    Address
    Suite 2510, China World Tower 3 No. 1 Jianguomenwai Avenue, Chaoyang District,...
    Telephone
    Telephone
    +(86-10) 5904 7300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.bpeasia.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/baring-private-equity-asia/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Baring PE Asia to buy Hinduja Global's healthcare arm for $1.2 billion
    Baring PE Asia to buy Hinduja Global's healthcare arm for $1.2 billion

    10 Aug 2021

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/baring-pe-asia-to-buy-hinduja-globals-healthcare-arm-for-1-2-billion/articleshow/85200076.cms

    ECONOMICTIMES
    10 Aug 2021
    Share Share
    Baring Private Equity Asia to acquire Lumenis
    Baring Private Equity Asia to acquire Lumenis

    20 Nov 2019

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/27/14925/baring-private-equity-asia-to-acquire-lumenis.html

    BIOSPECTRUM ASIA
    20 Nov 2019
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search